Pacific Edge Appoints Chief Operating Officer

Cancer diagnostics company Pacific Edge (NZX, ASX: PEB) is today pleased to announce the appointment of Darrell Morgan as Chief Operating Officer.

Darrell has extensive experience in senior leadership and executive roles in large, mid-sized and virtual pharmaceutical companies in the UK, Europe and New Zealand. He has more than 37 years’ experience in pharmaceutical R&D, immunodiagnostics and device development for drug delivery across human and animal health, in R&D, technical operations and customer-facing roles.

As Chief Operating Officer, Darrell will be a key leader in the Dunedin office, and responsible for Pacific Edge’s global laboratory operations, manufacturing, logistics, inventory management, the quality and regulatory compliance functions and operationalizing people and culture initiatives. He will have a focus on project management, people and culture, and operational excellence to optimize effectiveness, efficiency and on time delivery of products and services.

Darrell will join Pacific Edge on 3 October 2022 and report to Chief Executive Dr Peter Meintjes as a member of the C-Suite team. He will be based in Dunedin.

Since 2013, Darrell has been a senior leader with animal health company Argenta Research where his roles have included Global Head of Pharmaceutical Sciences, VP Customer Relationships – Pharmaceutical Sciences, and Product Development Director – Technical Operations. Prior to Argenta Research, he worked for global biopharmaceutical company UCB in the UK for eight years in senior roles with a focus on sterile drug product and medical device development.

Pacific Edge Chief Executive Dr Peter Meintjes, said: “We are delighted to welcome Darrell to Pacific Edge. His experience in global organizations of varied sizes in a range of roles focused on product and service delivery will be of great value to Pacific Edge and its partners and customers as we continue to drive increased adoption of our suite of Cxbladder diagnostics.”

Darrell said: “I have been impressed by the strong momentum I have seen from Pacific Edge as it expands globally, with a focus on the US. I look forward to working with the team to ensure quality and scale continues as the company grows.”

Darrell is a chartered biologist, with post graduate diplomas in industrial pharmaceutical sciences and management, people and change.

Released for and on behalf of Pacific Edge by Grant Gibson Chief Financial Officer.

Pacific Edge Appoints Chief Operating Officer

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Anti-spam verification:

Type the text you see in the image into the field below. You are asked to do this in order to verify that this enquiry is not being performed by an automated process.

Related News:

TWL - Share Purchase Plan Results
GMT revaluation, unit buyback and proposed structure update
Devon Funds Morning Note - 17 February 2026
CEN - Contact successfully completes NZ$450m Placement
February 17th Morning Report
PFI - Divestments
CEN offers to purchase remaining 25% of King Country Energy
February 16th Morning Report
SkyCity Appoints Chief Financial Officer
February 13th Morning Report